| Literature DB >> 28550263 |
Annachiara Cagnin1, Sara Mariotto2, Michele Fiorini2, Marina Gaule2, Nicola Bonetto1, Matteo Tagliapietra2, Emanuele Buratti3, Gianluigi Zanusso2, Sergio Ferrari2, Salvatore Monaco2.
Abstract
A novel neuronal tauopathy, mainly confined to hypothalamus and brainstem tegmentum, has recently been reported in patients with autoantibodies to the neuronal cell-adhesion molecule IgLON5. We describe a patient with anti-IgLON5 syndrome, who presented with dysautonomia and sleep disorder, followed by subacute dementia. Postmortem brain examination disclosed neuronal tau pathology prevailing in the hippocampus, amygdala, and locus coeruleus, in addition to microglial/neuronal TDP-43 pathology, with overexpression of aberrantly phosphorylated forms and neurotoxic truncated fragments, in basal ganglia, nucleus basalis, thalamus, and midbrain. These findings suggest that neurodegeneration in anti-IgLON5 syndrome might also occur via a microglia-triggered non-cell autonomous pathway.Entities:
Keywords: IgLON5; TDP-43 pathology; microglia; non-cell autonomous neurodegeneration; tauopathy
Mesh:
Substances:
Year: 2017 PMID: 28550263 DOI: 10.3233/JAD-170189
Source DB: PubMed Journal: J Alzheimers Dis ISSN: 1387-2877 Impact factor: 4.472